Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,416.40
+45.303.30%
Number of Gainers:7
Number of Losers:- -
Number of Flat:- -
PE:- -
High:1,423.43
Open:1,370.71
Low:1,370.71
Close:1,371.10
Volume:183.82M
Turnover:10.26B
Market Cap:1.49T
Float Cap:1.42T

Loading ...

Weight-Loss Drug Battle Escalates: CVS Health (CVS.US) Backs Novo Nordisk (NVO.US), Prompting Eli Lilly (LLY.US) to Switch Employee Benefits Provider

Stock News
·
4 hours ago

BRIEF-Lilly Drops CVS Drug Plan For Workers After Novo Obesity Deal - Bloomberg News

Reuters
·
8 hours ago

Pantera Minerals Defines New Exploration Targets at Gillham Project

TIPRANKS
·
13 hours ago

Government Shutdown Nears End, Lifting Investors' Spirits -- and Stocks -- WSJ

Dow Jones
·
13 hours ago

Moderna Inc. Stock Rallies 6.7%, Outperforms Peers

Dow Jones
·
13 hours ago

Sector Update: Health Care Stocks Climb Tuesday Afternoon

MT Newswires Live
·
16 hours ago

BRIEF-Trifecta Health Cooperated With Eli Lilly To Provide Patients With Access To Zepbound Single-Dose Vials

Reuters
·
19 hours ago

Altimmune Inc. Publishes Results of Phase 2b Trial of Pemvidutide in MASH

Reuters
·
Yesterday

Altimmune announces publication of IMPACT Phase 2b trial data

TIPRANKS
·
Yesterday

Trifecta Health: Cooperation With Lillydirect Pharmacy Channel Will Allow Patients to Receive Zepbound Delivered Directly to Them at Self-Pay Price

THOMSON REUTERS
·
Yesterday

Altimmune Announces Publication of Impact Phase 2B Trial Data in the Lancet and Concurrent Late-Breaking Oral Presentation at Aasld the Liver Meeting® 2025

THOMSON REUTERS
·
Yesterday

NOVO NORDISK CUTS PRICE OF WEIGHT-LOSS DRUG WEGOVY BY AS MUCH AS 33% IN INDIA, DOCUMENT SEEN BY REUTERS SHOWS

THOMSON REUTERS
·
Yesterday

Novo Nordisk's Expanded U.S. Patient Coverage Being Overlooked -- Market Talk

Dow Jones
·
Yesterday

Novo Nordisk Shares Seem Undervalued Ahead of Key Events -- Market Talk

Dow Jones
·
Yesterday

Novo Resources Unveils Promising Gold and Antimony Exploration Results in Pilbara

TIPRANKS
·
Yesterday

Viking Therapeutics Stock (VKTX) Jumps on Obesity Drug. Next Big Pharma Target?

TIPRANKS
·
Yesterday

Overnight Highlights Nov 11: U.S. Stocks Rise, XPeng Soars, Apple Delays Next iPhone Air, Pfizer Wins Metsera Bid

Deep News
·
Yesterday

BUZZ-Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles

Reuters
·
Yesterday

Merck's Heart Pill Slashes Cholesterol Levels in Test Patients -- Barrons.com

Dow Jones
·
Yesterday

Eli Lilly Stock Surges As Analyst Sees More Room To Run

Benzinga
·
Yesterday